These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9096988)

  • 1. Catheter survival during long-term insulin therapy with an implanted programmable pump. The Implantable Insulin Pump Trial Study Group.
    Scavini M; Galli L; Reich S; Eaton RP; Charles MA; Dunn FL
    Diabetes Care; 1997 Apr; 20(4):610-3. PubMed ID: 9096988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic procedures for catheter malfunction in programmable implantable intraperitoneal insulin infusion devices.
    Olsen CL; Turner DS; Iravani M; Waxman K; Selam JL; Charles MA
    Diabetes Care; 1995 Jan; 18(1):70-6. PubMed ID: 7698051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catheter complications associated with implantable systems for peritoneal insulin delivery. An analysis of frequency, predisposing factors, and obstructing materials.
    Renard E; Baldet P; Picot MC; Jacques-Apostol D; Lauton D; Costalat G; Bringer J; Jaffiol C
    Diabetes Care; 1995 Mar; 18(3):300-6. PubMed ID: 7555471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of an integrated sideport for diagnosis and management of decreased flow rates in a programmable implanted insulin delivery system. Implantable Insulin Pump Trial Study Group.
    Scavini M; Reich S; Eaton RP; Charles MA; Dunn FL
    Artif Organs; 1996 Sep; 20(9):991-6. PubMed ID: 8864020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial of programmable implantable insulin pump for type I diabetes.
    Selam JL; Micossi P; Dunn FL; Nathan DM
    Diabetes Care; 1992 Jul; 15(7):877-85. PubMed ID: 1516508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM. A multicenter study. The EVADIAC Study Group. Evaluation dans le Diabète du Traitement par Implants Actifs.
    Hanaire-Broutin H; Broussolle C; Jeandidier N; Renard E; Guerci B; Haardt MJ; Lassmann-Vague V
    Diabetes Care; 1995 Mar; 18(3):388-92. PubMed ID: 7555483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term therapy of IDDM with an implantable insulin pump. The Implantable Insulin Pump Trial Study Group.
    Dunn FL; Nathan DM; Scavini M; Selam JL; Wingrove TG
    Diabetes Care; 1997 Jan; 20(1):59-63. PubMed ID: 9028695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience.
    Gin H; Renard E; Melki V; Boivin S; Schaepelynck-Bélicar P; Guerci B; Selam JL; Brun JM; Riveline JP; Estour B; Catargi B;
    Diabetes Metab; 2003 Dec; 29(6):602-7. PubMed ID: 14707889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method for assessing catheter patency in implanted pumps for long-term intraperitoneal insulin delivery.
    Scavini M; Hammarberg B; Dosio F; Torri M; Petrella G; Galimberti G; Vai S; Fazio F; Pozza G
    Artif Organs; 1997 May; 21(5):405-8. PubMed ID: 9129773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin underdelivery from implanted pumps using peritoneal route. Determinant role of insulin pump compatibility.
    Renard E; Bouteleau S; Jacques-Apostol D; Lauton D; Gibert-Boulet F; Costalat G; Bringer J; Jaffiol C
    Diabetes Care; 1996 Aug; 19(8):812-7. PubMed ID: 8842596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Best Ways and Practices to Avoid Insulin Pump Catheter Occlusions.
    Slover RH
    Diabetes Technol Ther; 2016 Mar; 18(3):118-9. PubMed ID: 26950802
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term intraperitoneal insulin delivery.
    Pitt HA; Saudek CD; Zacur HA
    Ann Surg; 1992 Oct; 216(4):483-91; discussion 491-2. PubMed ID: 1417197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of abdominal location of the catheter on the efficacy of intraperitoneal insulin infusion using implantable and programmable pumps in type I diabetes.
    Pinget M; Jeandidier N; Keipes M; Louy S; Vetter A
    Transplant Proc; 1992 Jun; 24(3):945-6. PubMed ID: 1604676
    [No Abstract]   [Full Text] [Related]  

  • 14. Intraperitoneal insulin absorption after long-term intraperitoneal insulin therapy.
    Scavini M; Pincelli A; Petrella G; Galimberti G; Zager PG; Torri M; Pozza G
    Diabetes Care; 1995 Jan; 18(1):56-9. PubMed ID: 7698048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience of long-term intraperitoneal insulin treatment using a new percutaneous access device.
    Wredling R; Adamson U; Lins PE; Backman L; Lundgren D
    Diabet Med; 1991 Jul; 8(6):597-600. PubMed ID: 1832367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term implantation of a new implantable programmable insulin pump in two diabetic dogs.
    Scavini M; Day PW; Eaton RP
    Artif Organs; 1992 Oct; 16(5):518-22. PubMed ID: 10078304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pump-pocket complications during long-term insulin delivery using an implanted programmable pump.
    Scavini M; Cristallo M; Sarmiento M; Dunn FL
    Diabetes Care; 1996 Apr; 19(4):384-5. PubMed ID: 8729167
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced Silent Occlusions with a Novel Catheter Infusion Set (BD FlowSmart): Results from Two Open-Label Comparative Studies.
    Gibney M; Xue Z; Swinney M; Bialonczyk D; Hirsch L
    Diabetes Technol Ther; 2016 Mar; 18(3):136-43. PubMed ID: 26701357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage activation in type 1 diabetic patients with catheter obstruction during peritoneal insulin delivery with an implantable pump.
    Kessler L; Tritschler S; Bohbot A; Sigrist S; Karsten V; Boivin S; Dufour P; Belcourt A; Pinget M
    Diabetes Care; 2001 Feb; 24(2):302-7. PubMed ID: 11213883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for extended lifetime of implantable intraperitoneal insulin catheters.
    He J; Renard E; Lord P; Cohen D; Gu B; Wang X; Yenduri G; Burgess DJ
    J Control Release; 2022 Jan; 341():487-497. PubMed ID: 34856228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.